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SIGMAR1 gene encodes a non-opioid endoplasmic reticu-
lum (ER) protein which is involved in a large diversity of cell 
functions and is expressed ubiquitously in both central and 
peripheral nervous systems. Alterations of its normal func-
tion may contribute to two different phenotypes: juvenile 
amyotrophic lateral sclerosis (ALS 16) and distal hereditary 
motor neuropathies (dHMN). We present the case of a female 
patient, of 37-years-old, with distal muscle weakness and atro-
phy beginning in childhood and slowly progressive in the first 
two decades of life. Neurological examination revealed a sym-
metrical severe muscle wasting and weakness in distal lower 
and upper limbs, with claw hands, footdrop with equinovarus 
deformity and hammer toes, generalized areflexia and normal 
sensory examination. The electrodiagnostic study revealed 
a pure chronic motor peripheral nerve involvement without 
signs of demyelination. The molecular study found the dele-
tion c.561_576del on exon 4 and a deletion of all exon 4, in the 
SIGMAR1 gene.
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Introduction
The Distal Hereditary Motor Neuropathies (dHMN) 
comprise a heterogeneous group of diseases that share 
the common feature of a length-dependent predominant-
ly motor neuropathy (1). To date 19 causative genes and 
four loci have been identified with autosomal dominant, 
recessive and X-linked patterns of inheritance  (2). De-
spite advances in the identification of novel gene muta-
tions, 80% of patients with dHMN have a mutation in an 
as-yet undiscovered gene (3).
The sigma-1 receptor (s1R) encoded by the SIGMAR1 
gene, is a non-opioid endoplasmic reticulum (ER) protein, 
with a molecular mass of 24 kDa, which is involved in a 
large diversity of cell functions and is expressed ubiquitous-
ly in both central and peripheral nervous systems (4, 5). It is 
enriched in motor neurons of the brainstem and spinal cord 
and plays a role in wide variety of cellular functions being 
critical for neuronal survival and maintenance (6). Protein 
abnormal function has been implicated in several diseases 
such as Alzheimer’s disease, schizophrenia, stroke, cogni-
tion and depression (5). More recently it has been associ-
ated with two different phenotypes of motor neuron dis-
ease: juvenile amyotrophic lateral sclerosis (ALS 16) (7) 
and distal hereditary motor neuropathy (dHMN) (2).
We present the clinical, neurophysiologic and mo-
lecular findings of a Portuguese patient with dHMN 
caused by a heterozygous compound mutation in the 
SIGMAR1 gene.
Case report
The patient is a 37-year-old woman, the second off-
spring of a non-consanguineous couple. The patient’s de-
livery was normal and she presented normal motor and 
intellectual development in the first years of life. She at-
tended school successfully until the age of 15. There was 
no history of neuromuscular diseases in the family. 
At the age of 4 it was noticed a different way of walk-
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ing, clumsier with increasing falls. By the same time, she 
developed progressive distal muscle wasting and weak-
ness of the lower limbs, more evident on the right foot. 
Her medical records from the pediatric orthopedic ap-
pointments reported feet orthopedic corrective surgeries 
performed at 8 and 10 years of age.
At the age of 16, the muscle weakness had progressed 
to involve the distal parts of upper limbs, with significant 
difficulty with fine hand movements. Since the end of the 
second decade, her neurological condition became stable.
At the age of 37, she presented symmetrically severe 
muscle wasting and weakness in distal lower and upper 
limbs, bilateral footdrop with equinovarus deformity and 
claw hands (Fig. 1). Walking was impossible on tiptoes 
and heels. There was no evidence of fasciculation or up-
per motor neuron signs, nor signs of bulbar involvement. 
Muscle stretch reflexes were abolished throughout. Sen-
sory examination was normal. 
Neurophysiologic study showed normal sensory 
responses and unobtainable motor responses when re-
corded over the intrinsic muscles of the hands and feet. 
Muscle needle examination showed a few fibrillations 
potentials and positive sharp waves in the intrinsic mus-
cles of the hands and feet and in the tibialis anterior bi-
laterally. These muscles were not voluntarily activated 
and motor unit potentials of increased duration and 
amplitude were recorded in the arm and forearm mus-
cles and in the vastus medialis muscles, together with a 
significantly reduced muscle recruitment pattern. Ven-
tilatory parameters were all normal, as well the cardiac 
evaluation. The parents had a normal clinical and neuro-
physiologic examination.
The molecular study (Fig.  2) included polymerase 
chain reaction and sequencing of the entire coding region, 
including the adjacent intronic regions, of the SIGMAR1 
gene (chromosome 9). Reference sequence: NM_005866. 
It was found a frameshift/truncating hemizygous muta-
tion, variant c.561_576del on exon 4 (p.Asp188Profs*69), 
and a macrodeletion encompassing all exon 4. These al-
terations were identified on father and mother, respectively. 
The c.561_576del on exon 4 (p.Asp188Profs*69) mutation 
is predicted to be pathogenic as it introduces a premature 
stop codon 69 aminoacids downstream, producing a trun-
cated protein.
Discussion
The s1R plays an important role in cell mainte-
nance and survival and its loss or malfunction causes 
Figure 1. Claw hands with atrophy of the intrinsic hand 
muscles (A, B, C); Circumferential atrophy of distal legs 
with footdrop (D, E, F).
Figure 2. Sequencing electropherograms of proband (A) and both parents (B: father; C: mother). The deletion 
c.561_576del (arrow) is evident on both proband (A) and father (B). There is no evidence of the same deletion on 
mother’s electropherogram (box) leading to the conclusion of a macrodeletion of all exon 4.
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ER–mitochondria disconnection and ER stress activa-
tion and disrupts mitochondrial function and axonal 
transport, leading to axonal motor neuron degenera-
tion with consequent cell death  (8). This dying-back 
degeneration process would be consistent with the dis-
tal predominant pattern of motor involvement observed 
in patients with SIGMAR1 gene mutations (9).
The clinical presentation of the first Portuguese 
patient with dHMN caused SIGMAR1 gene mutations, 
has been previously reported  (2). Similar to our pa-
tient, there was a clinical onset of a pure motor pe-
ripheral nerve involvement in the first decade of life, 
predominantly distal in lower limbs associated with 
feet deformities and subsequent progression to the up-
per limbs. There were no sensory symptoms or cogni-
tive impairment, upper motor neuron signs or bulbar 
involvement. Our patient is still able to walk without 
support and she participated in the community activi-
ties.
However, recent reports suggest that SIGMAR1 
gene mutations should take part of the pool of genes 
that can cause overlapping motor neuron/nerve phe-
notypes, much like BSCL2- and REEP1-related disor-
ders (9), as well as the recently described KIF5A (10), 
on either case there might be a combination of dHMN 
and pyramidal tract signs.
The rarity of dHMN and the even more rare dHMN 
caused by mutations of the SIGMAR1 gene, with the 
few clinical cases described in the literature, make it 
difficult to be certain about the phenotypes that are as-
sociated with mutations of the SIGMAR1 gene.
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